URMC / Pathology & Laboratory Medicine / News / Technical Bulletins Technical Bulletins About The following technical bulletins are memos distributed to the UR Medicine Labs partners and affiliates. They are distributed via email and posted here for reference. 2024 Bulletins POST CRTT Memo PCR B-Cell clonality testing: send out to ARUP TB Cell Subset- ARUP Memo Blood Gas Testing Changes Memo Cumulative Antibiograms for Community Outpatient Infections Interferon Gamma Release Assay New Test Platform Herpes Simplex Virus (HSV) Type 1&2 IgM: Test Discontinued Confirmation Barbiturates: Change in Testing Laboratory/Reportable Range Myeloid NGS Panel Change in Assay Platform Bone Marrow Engraftment Monitoring Chimerism Assay Kit Change CJD/Prion Markers: Delay in Testing for total Tau Protein Memo HLACD Risk Assessment Update Memo ImmunoCAP Allergy: New In-house Tree Nut Component Testing Memo New Lung Cancer Molecular Panel Memo HHV-6A/B Quantitative NAAT, Plasma: New test CBC/D Modernization and Simplification Memo MMRV Memo Heme Malignancy (NGSH) Panl Re-activated in eRecord Plasma Metanephrines: Increased Stability Time and Room Temperature Shipping Celiac EBV Serology Memo UNGAL Testing in Urine: New In House Test 2023 Bulletins Hemolysis Interference Update Memo Pediatric GFR Equation Update Memo Updated Names for Testosterone Orders Molecular Test Reporting Changes Discontinuation of Caffeine Testing Memo HIV-1/2 Qualitative NAAT Memo Fondaparinux (Aristra) Anti-Xa-Cessation of Testing Memo DD Stability Increase Memo Change in ordering EGFR, KRAS and NRAS Collection and Transport of Urine for Culture and Urinalysis CEBPA Memo Celiac tTG DGP Memo CBCD Reference Ranges Memo Changes to Flow Cytometry TSH Reflex to Free T4 Memo DAU Memo Microarray Memo RHIO Downtime Notification ImmunoCAP Allergy: Peanut Components Memo Change in Folate Testing Lab Alcohol Panel Update Buprenorphine Change in Testing Lab Hemolysis Interference Update 2022 Bulletins Total/Free and Total Testosterone Orders Updated Options Memo Reticulocyte Count Update Memo Solid Tumor Next Generation Sequencing Delays Factor X Chromogenic Testing Discontinuation Memo Interferon Gamma Release Assay: Rebuilt Molecular Delays Memo Blood Bank Testing-Updated Specimen Tube Type (Revised) Apixaban Memo Tacrolimus and Cyclosporine Memo Pathology Delays BK Virus Quantitative NAAT Change to Assay Blood Lead Capillary and Venous Memo Blood Bank Testing-Updated Tube Type Adenovirus Quantitative NAAT New Test Memo UCDS Memo Lyme Testing Guidance for Healthcare Providers Anti-HBclgM Memo ImmunoCAP Interpretation Memo eGFR Updated Calculation Memo hsTnT Memo HPV Memo 2021 Bulletins Post-Vasectomy Semen Analysis: SMH ONLY Change to C. difficile Testing Algorithm Maternal Screen Testing: Change in Testing Laboratory Rheumatoid Factor with Reflex to Titer: Change to Assay Streptolysin O Antibody (ASO) Return to In House Testing Epstein-Barr Virus (EBV) Quantitative PCR, Plasma New Assay BCR-ABL1 Major Quantitavie Testing APIA PPIA Testing Now Available Meningitis Encephalitis PCR Panel: Temporarily Limited Panel BCR-ABL1 Quantitative Testing Cystatin C: New Test In-House Streptolysin O Antibody (ASO) Temporary Change to Turn-around Time Microarray 044k Discontinued Test PathDelays QuantiFERON TB Analyzer: Delay in Testing SARS-CoV-2 Antibody (IgG), Spike Protein Urine ETG: Change in Performing Laboratory Critical Shortage of Blue-Top Blood Collection Tubes-Suspension of Testing Immunotyping: Addition of Testing Platform Citrate Tube Critical Shortage Notification Critical Glucose Update for Newborns Positive Bias for Creatinine Results C-Reactive Protein (CRP): New Reference Range Random High Sensitivity Troponin: Expansion of Testing Euglobulin Clot Lysis Time: Cessation of Testing Homocysteine: Change in Specimen Requirements Aspirin Platelet Inhibition - Collection Tube Shortage QuantiFERON TB Analyzer: Delay in Testing Meningitis Encephalitis PCR Panel: Resume In-House Testing CMV Virus Testing for Neonatal Samples: Return to on-site testing Urine Ethyl Glucuronide: Change in Performing Laboratory Molecular Diagnostics Testing: Change in Performing Laboratory 2020 Bulletins CMV Virus Testing for Neonatal Samples: Reagent Shortage Microsatellite Instability (MSI): New Molecular Diagnostics Test Meningitis Encephalitis PCR Panel: Reagent Shortage Epstein Barr Virus (EBV) Serology: Change to Assay Urine Ethyl Glucuronide: Change in Performing Laboratory Coagulation Testing: Updated Reference Ranges COVID-19 Testing: New Reporting Requirements Serum Free Light Chains Assay: Change to Testing Platform Urinalysis: Change in Testing Platform Semi-Quantitative THC: Change in Testing Methodology Allergy Testing: Change in Specimen Storage Policy SARS-CoV-2 Antibody (IgG) Testing: New Assay Urine Ethyl Glucuronide: Change in Performing Laboratory Urine Drug Confirmation Testing: Change in Performing Laboratory Buprenorphine Testing: Update to Assay COVID19 Testing Guidelines for Healthcare Providers Procalcitonin: Change to Testing Platform 2019 Novel Coronavirus: Guidelines for Patients Under Investigation Heparin-Induced Thrombocytopenia (HITAB): Update to Testing Cryptococcal Antigen: Change to Assay 2019 Bulletins New CMS Regulations Regarding Molecular Pathology Mycoplasma genitalium NAAT on genitourinary specimens: New Assay BHCG Tumor Marker: New Assay Urine Drug Screenings: Testing Updates Vitamin D Testing: Change to Assay Vitamin D: Delay in Testing Saliva Cortisol Testing: Temporary Change in Performing Laboratory Urine Drug Confirmation Testing: Temporary Change in Performing Laboratory Meningitis and Encephalitis Panel: New Assay Chlamydia (PDC) and Gonorrhoeae (PDG) Testing: Change to Assay Chromosome Microarray (MaCGH) Laboratory Testing New CMS Regulations Regarding Molecular Pathology Patient Service Center Hours of Operation Notice Detection of Viral Pathogens in Stool: Change to Assay Maternal Screen Testing: Temporary Change in Testing Laboratory Complete (comprehensive) Semen Analysis Panel: Change to Testing Molecular Diagnostics Laboratory Testing UR Medicine Laboratory Relocation Project Urine Hemosiderin: Change in Performing Laboratory Total Iron Binding Capacity (TIBC): Change in Methodology Required regulatory information: Immunophenotyping by Flow Cytometry Lyme Disease Antibody Testing: Change to Assay Congenital Cytomegalovirus (CMV): New Assay High Dose Biotin May Interfere with Lab Tests Urinalysis reflex testing (UAR and UARWC): New Reflex Criteria Glucose: Critical Value Change Magnesium (Mg) and Creatine Kinase (CK): Change in Reporting 2018 Bulletins Anti-Cardiolipin (aCL) IgG/IgM and Beta-2 Glycoprotein I (aB2GPI) IgG/IgM: Change to Assay Buprenorphine Test for UR Medicine Emergency Departments Fentanyl: Change in Screening Anti Mullerian Hormone Assay Elution Swabs™ (ESwabs) for Bacterial and Fungal Culture Chlamydia/GC/Trichomonas PCR Platform Change Hemoglobin A1c: Change in Assay Virus-Specific PCR Tests Replacing Viral Culture Respiratory Viruses testing Measles or Mumps viruses by PCR Creatine Kinase MB (CK-MB): Change in Testing QuantiFERON® TB (M.Tuberculosis exposure): Change in Testing Thyroglobulin and Related Antibodies: Notification of Assay Changes Anti-Cyclic Citrillinated Peptide (CCP) IgG: Change to Assay Chlamydia, Gonorrhoeae, and Trichomonas Test Delays ROMA (Risk of Ovarian Malignancy Algorithm) New High Sensitivity (HS) Troponin Assay Thromboelastography Testing (TEG): Critical Values BD Affirm Collection and Transport System for Triple Screen HSV-1 and HSV-2 Type Specific IgG Antibodies: Change to Assay Hemoglobin Electrophoresis Consent Older Bulletins